HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thalidomide administration for the treatment of resistant plasma cell leukemia.

AuthorsStavroula Tsiara, Aristeidis Chaidos, Helen Kapsali, Evagelia Tzouvara, Konstantinos L Bourantas
JournalActa haematologica (Acta Haematol) Vol. 109 Issue 3 Pg. 153-5 ( 2003) ISSN: 0001-5792 [Print] Switzerland
PMID12747371 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Angiogenesis Inhibitors
  • Thalidomide
Topics
  • Adjuvants, Immunologic (adverse effects, therapeutic use)
  • Aged
  • Angiogenesis Inhibitors (adverse effects, therapeutic use)
  • Drug Tolerance
  • Female
  • Humans
  • Leukemia, Plasma Cell (drug therapy, etiology)
  • Middle Aged
  • Multiple Myeloma (complications, therapy)
  • Thalidomide (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: